HMOX1 and breast carcinoma: Nuclear factor erythroid 2-related factor 2 (NRF2) exerts its antioxidant effects by upregulating the expression of genes related to iron and ROS metabolism and HO-1 to reduce ROS levels, increasing chemoresistance and ferroptosis resistance in breast cancer cells.